МедУнивер - MedUniver.com Все разделы сайта Видео по медицине Книги по медицине Форум врачей  
Рекомендуем:
Кардиология:
Кардиология
Основы кардиологии
Аритмии сердца
Артериальная гипертензия - гипертония
ВСД. Нейроциркуляторная дистония
Детская кардиология
Сердечная недостаточность
Инфаркт миокарда
Ишемическая болезнь сердца
Инфекционные болезни сердца
Кардиомиопатии
Болезни перикарда
Фонокардиография - ФКГ
Электрокардиография - ЭКГ
ЭхоКС (ЭхоКГ, УЗИ сердца)
Бесплатно книги по кардиологии
Пороки сердца:
Врожденные пороки сердца
Приобретенные пороки сердца
Форум
 

Список использованной литературы при подготовке статей по оценке жизнеспособного миокарда

1. ACC/AHA/ASE 2003 Guideline Update for the Clinical Applicatoin of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Competence, www. americanheart.org

2. Afridi I, Graybum PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998;32:921-6.

3. Afridi I, Kleinian NS, Raizner AE, Zoghbi W. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663 70.

4. Allman КС, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.

5. Anselmi M, Golia G, Cicoira M et al. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol 1998;81:21G-28G.

6. Baer FM, Theissen P, Schneider CA et al. Dobutamine magnetic resonance imaging predicts recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-8.

7. Baer FM, Theissen P, Schneider CA, Voth E, Schicha H, Sechtem U. Magnetic resonance imaging techniques for the assessment of residual myocardial viability. Herz 1994;19:51-64.

8. Baumgartner H, Porenta G, Lau YK et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol 1998;32:1701-8.

9. Bax J J, Poldermans D, Elhendy A et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularisation in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-169.

10. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.

11. Beanlands RS, deKemp RA, Smith S et al. F-18fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function. Am J Cardiol 1997;79:1092-5.

12. Beanlands RS, Hendry P, Masters R et al. Delayed revascularization is associated with increased mortality in patients with severe LV dysfunction and viable myocardium on FDG PET imaging. Circulation 1997;96:1-434.

13. Becker LC, Levine JH, Di Paula AF, Guamim T, Aversano T. Reversal of dysfunction in postis-chemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 1986;7:580-9.

14. Beller GA. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability. QJ Nucl Med 1998;40:55-67.

15. Bolli R. Mechanism of myocardial «stunning». Circulation 1990;82:723-38.

16. Bolli R. Myocardial «stunning» in man. Circulation 1992;86:1671-91.

17. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.

18. Cigarroa CG, de Filippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.

19. Cleland JGF, Freemantle N, Ball SG et al. The heart failure revascularization trial (HEART): rationale design and methodology. Eur J Heart Fail 2003;5:295-303.

20. Cornel JH. Bax JJ, Elhendy A et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998;31:1002-10.

21. Cornel JH, Bax JJ, Fioretti PM. Assessment of myocardial viability by dobutamine stress echocardiography. Curr Opin Cardiol 1996; 11:621—6.

22. Di Carli MF, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.

23. Diamond GA, Forrester JS, De Luz PL, Wyatt HL, Swan JHC. Postextrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978;95:204-9.

24. Duncan AM, O’Sullivan CA, Carr-White GS et al. Long axis electromechanics during dobutamine stress in patients with coronary artery disease and left ventricular dysfunction. Heart 2001;86:397-404.

25. Ellis SG, Wynne J, Braunwald E, Henschke Cl, Sander T, Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J 1984;107:13-9.

26. Elsasser A, Schlepper M, Kloverton WP, Cai WJ, Zimmermann R, Muller KD. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920-31.

27. Force T, Kemper A, Perkins L, Gilfoil M, Cohen C, Parisi AF. Over-estimation of infarct size by quantitative two-dimensional echocardiography: the role of tethering and of analytic procedures. Circulation 1986;73:1360-8.

28. Galiuto L, lliceto S. Myocardial contrast echocardiography in the evaluation of viable myocardium after acute myocardial infarction. Am J Cardiol 1998;81:29G-32G.

29. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P. Effects of nitroglycerin by technetium-99 m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994;74:843-8.

30. Gerber BL, Vanoverschelde JL, Bol A et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.

31. Gorcsan Jill, Deswal A. Mankad S et al. Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. Am J Cardiol 1998;81:615-23.

32. Gunning MG, Anagnostopoulos C, Knight CJ et al. Comparison of 201T1,99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998;98:1869-74.

33. Haas F, Haehnel CJ, Picker W et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693-1700.

34. Hanekom L, Jenkins C, Jeffries L et al. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography. A follow-up study after revascularization. Circulation 2005; 112:3892-900.

35. Hennessy T, Diamond P, Holligan В et al. Assessment of inotropic reserve using dobutamine stress echocardiography and its relation to myocardial histological changes in dysfunctional myocardial segments. Eur Heart J 1997;18(Sup-pl.):243 50.

36. Heyndrickx GR, Millard RW, McRitchie R.I. Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.

37. Hoffer EP, Dewe W, Celentano C, Pierard LA. Low-level exercise echocardiography detects contractile reserve and predicts reversible dysfunction after acute myocardial infarction: comparison with low-dose dobutamine echocardiography. J Am Coll Cardiol 1999;34:989-97.

38. Hoffmann R, Altiok E, Nowak В et al. Strain rate measurement by Doppler echocardiography allows improved assessment of myocardial viability in patients with depressed left ventricular function. J Am Coll Cardiol 2002;39:443-9.

39. Hoffmann R, Lethen H, Marwick T et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996;27:330-6.

40. Hoffmann R, Lethen H, Marwick T et al. Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation. Am J Cardiol 1998;82:1520-4.

41. Iliceto S, Galiuto L, Marchese A et al. Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996;77:441-5.

42. Ito BR, Libraty DH, Engler RL. Effect of transient coronary occlusion on coronary blood flow autoregulation, vasodilatator reserve and response to adenosine in the dog. J Am Coll Cardiol 1991;18:858-67.

43. Ito H, Iwakura K, Oh H et al. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation 1995;91:650-62.

44. Ito H, Tomooka T, Sakai N et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.

45. Kaul S. Dobutamine echocardiography for determining myocardial viability after reperfusion: Experimental and clinical observations. Eur Heart J 1995;16:17-23.

46. La Canna G, Alfieri O, Giubbini M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.

47. Lancellotti P, Hoffer EP, Pierard LA. Detection and clinical usefulless of a biphasic response during exercise echocardiography early after myocardial infarction. J Am Coll Cardiol 2003;41:1142-7.

48. Leaf A. Cell swelling: a factor in ischemic tissue injury. Circulation 1973;48:455-8.

49. Lee HH, Davila-Roman VG, Ludbrook PA et al. Dependency of contractile reserve on myocardial blood flow: implications for the assessment of myocardial viability with dobutamine stress echocardiography. Circulation 1997;96:2884-91.

50. Lieberman AN, Weiss JL, Jugdutt BI et al. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981;65:759-66.

51. Ma L, Chen L, Gillam L, Waters DD, Chen C. Nitroglycerin enhances the ability of dobutamine stress echocardiography to detect hibernating myocardium. Circulation 1997;96:3992—4001.

52. Mahrholdt H, Wagner A, Holly ТА et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106:2322-7.

53. Meza MF, Kates MA, Barbee RW et al. Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from intarcted myocardium. J Am Coll Cardiol 1997;29:974-84.

54. Nixdorff U, Horstick G, Mohr-Kahaly S, Heiman A, Kempski O, Meyer J. Tissue Doppler echocardiography: quantitative ischemia and viability evaluation in an occlusion and reperfusion pig model. J Am Soc Echocardiogr 1998; 11: 548.

55. Nixdorff U, Matschke C, Winklmaier M et al. Native tissue second harmonic imaging improves endocardial and epicardial border definition in dobutamine stress echocardiography. Eur J Echocardiography 2001;2:52-61.

56. Nixdorff U, Mohr-Kahaly S, Kremer M, Rippin G, Meyer J. Quantitative tissue Doppler echocardiography: physiologic nonuniformity of left ventricular transmural myocardial wall velocities and gradients. Echocardiography 1997:14: 545-52.

57. Nixdorff U, Rupprecht H-J, Mohr-Kahaly S, Kremer M, Bickel C, Meyer J. Tissue Doppler echocardiography: a new method of evaluating perfusion-dependent myocardial function during PTCA. Int J Cardiac Imag 1997;13:99-103.

58. Nixdorff U, Schmidseder F, Andreas J, Mohr-Kahaly S, Meyer J, Daniel WG. Dobutamine echocardiography differentiate hibernating from stunning. J Am Coll Cardiol 1999; 33(Suppl.A):445A.

59. Nixdorff U, Stein R, Erbel R. Rupprecht H-J, Spiecker M, Meyer J. PTCA-induzierte Myokar-dischamie zum Nachweis von gerettetem Myo-kard nach thrombolytischerTherapie des akuten Myokardinfarktes. Z Kardiol 1995;84:503-11.

60. Nixdorff U, Wagner S, Erbel R, Weitzel P, Mohr-Kahaly S, Meyer J. Normative values for dobutamine stress-echocardiography. Dtsch Med Wschr 1995;120:1761-7.

61. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin J, Vanoverschelde JLJ. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999;100:141-8.

62. Picano Е, Lattanzi F, Orlandini A, Marinic С, l’Abbate A. Stress echocardiography and the human factor: The importance of being expert. J Am Coll Cardiol 1991;17:666-9.

63. Picano E, Ostojic M, Varga A et al. Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability. JAm Coll Cardiol 1996;27:1422-8.

64. Pierard LA, de Landsheere CM, Berthe C, Rigol P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31.

65. Poli A, Previtali M, Lanzarini L et al. Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis. Heart 1996;75:240-6.

66. Pontillo D, Capezzuto A, Achilli A, Guerra R, Carboni GP. Nitrate echocardiography for the detection of viable myocardium after myocardial infarction: comparison with delayed thallium scintigraphy. G Ital Cardiol 1993;23:1187-94.

67. Rahimtoola SH. Importance of diagnosing hibernating myocardium how and in whom? Editorial comment. J Am Coll Cardiol 1997;30:1701-6.

68. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.

69. Rasmussen S, Corya B, Feigenbaum H, Knoebel S. Detection of myocardial scar tissue by M-mode echocardiography. Circulation 1978;57:230-8.

70. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. I Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-94.

71. Rinaldi CA, Masani ND, Linka AZ, Hall RJ. Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning? Heart 1999;81:404-11.

72. Schaper W. «Hibernating myocardium». Zeit fur einen Paradigmenwechsel (Editorial). Z Kardiol 1991;80:712-5.

73. Schulz R, Heusch G. Characterization of hibernating and stunned myocardium. Eur Heart J 1995; 16(Suppl.): 19-25.

74. Schwaiger M, Bull U, Hor G et al. Indications for clinical application of positron emission tomography in cardiology. Z Kardiol 1996;85: 453-68.

75. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after rervascularisation in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848-1854.

76. Shinoni S, Frangogiannis G, Aggeti CJ et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography. Circulation 2002;107:538-44.

77. Smith SC, Dove JT, Jacobs AK et al. ACC/AHA Guidelines for percutaneous coronary Intervention (revision of the 1993 PTCA guidelines). Circulation 2001; 103:3019-41.

78. Underwood SR, Bax JJ, vom Dahl J et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 2004;25:815-36.

79. Vanoverschelde JLJ, Wijns W, Depre C et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral dependent myocardium. Circulation 1993;87:1513-23.

80. Varga A, Ostojic M, Djordjevic-Dikic A et al. Infra-low dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. Eur Heart J 1996;17:629-34.

81. Volpi A, De Vita C, Franzosi GM, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G. The Ad hoc Working Group of the Gruppo Italiano della Sopravivenza nell’Infarto Miocardico (GISSI)-2 Data Base. Determinants of 6 months mortality in survivors of myocardial infarction after thrombolysis. Circulation 1993;88:416-29.

82. Wagner A, Mahrholdt H, Regenfus M etal. Contrast-enhanced MR and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.

83. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. .1 Am Coll Cardiol 1996;27:132-9.

- Также рекомендуем "Дилатационная кардиомиопатия (ДКМП): клиника, диагностика, дифференциация"

Редактор: Искандер Милевски. Дата публикации: 29.12.2019

Медунивер - поиск Мы в Telegram Мы в YouTube Мы в Вконтакте Мы в Instagram Форум консультаций наших врачей Контакты и реклама
Информация на сайте подлежит консультации лечащим врачом и не заменяет очной консультации с ним.
См. подробнее в пользовательском соглашении.